StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Medpace's operating cash flow for the twelve months ending Sep 30, 2026 was $723.05M, up 1.7% year over year. For fiscal 2025 it was $713.22M, up 17.1% from the year before. Over ten years it grew 23.6% a year on average. The highest annual figure on record is $713.22M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$713.22M+17.1%
FY2024Dec 31, 2024$608.82M+40.5%
FY2023Dec 31, 2023$433.37M+11.7%
FY2022Dec 31, 2022$388.05M+47.4%
FY2021Dec 31, 2021$263.33M+1.8%
FY2020Dec 31, 2020$258.68M+28.1%
FY2019Dec 31, 2019$201.87M+28.9%
FY2018Dec 31, 2018$156.58M+60.8%
FY2017Dec 31, 2017$97.39M+6.2%
FY2016Dec 31, 2016$91.73M+6.8%
FY2015Dec 31, 2015$85.87M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$216.60M-12.0%
Q2 FY2026Jun 30, 2026$162.01M+9.1%
Q1 FY2026Mar 31, 2026$151.79M+20.6%
Q4 FY2025Dec 31, 2025$192.65M+1.0%
Q3 FY2025Sep 30, 2025$246.21M+65.2%
Q2 FY2025Jun 30, 2025$148.53M+27.6%
Q1 FY2025Mar 31, 2025$125.84M-17.6%
Q4 FY2024Dec 31, 2024$190.67M+21.9%
Q3 FY2024Sep 30, 2024$149.08M+30.3%
Q2 FY2024Jun 30, 2024$116.40M+41.1%
Q1 FY2024Mar 31, 2024$152.68M+90.7%
Q4 FY2023Dec 31, 2023$156.40M+14.4%
Q3 FY2023Sep 30, 2023$114.39M+5.4%
Q2 FY2023Jun 30, 2023$82.52M-14.6%
Q1 FY2023Mar 31, 2023$80.08M+73.1%
Q4 FY2022Dec 31, 2022$136.68M+92.8%
Q3 FY2022Sep 30, 2022$108.49M+49.9%
Q2 FY2022Jun 30, 2022$96.62M+53.9%
Q1 FY2022Mar 31, 2022$46.26M-19.3%
Q4 FY2021Dec 31, 2021$70.89M-32.8%
Q3 FY2021Sep 30, 2021$72.35M+21.1%
Q2 FY2021Jun 30, 2021$62.76M+41.8%
Q1 FY2021Mar 31, 2021$57.32M+16.6%
Q4 FY2020Dec 31, 2020$105.50M+85.3%
Q3 FY2020Sep 30, 2020$59.76M-7.0%
Q2 FY2020Jun 30, 2020$44.27M-5.1%
Q1 FY2020Mar 31, 2020$49.15M+44.5%
Q4 FY2019Dec 31, 2019$56.94M+44.4%
Q3 FY2019Sep 30, 2019$64.29M+22.5%
Q2 FY2019Jun 30, 2019$46.63M+12.8%
Q1 FY2019Mar 31, 2019$34.01M+46.0%
Q4 FY2018Dec 31, 2018$39.44M+37.7%
Q3 FY2018Sep 30, 2018$52.50M+34.6%
Q2 FY2018Jun 30, 2018$41.34M+36.0%
Q1 FY2018Mar 31, 2018$23.30M–
Q4 FY2017Dec 31, 2017$28.65M-1.4%
Q3 FY2017Sep 30, 2017$39.00M–
Q2 FY2017Jun 30, 2017$30.41M–
Q1 FY2017Mar 31, 2017-$675.00K–
Q4 FY2016Dec 31, 2016$29.07M–

More Medpace figures

See a number that looks wrong?